Pharma-Bio Serv, Inc. (OTCPK: PBSV)
Health Care · Life Sciences Tools & Services · US
$0.48
-4.00% today · -21.3% 1Y
Pharma-Bio Serv, Inc. (OTCPK: PBSV) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $10.99M and employs 55 people.
Over the last twelve months the share price has lost 21.3%, trading between 0.32 and 0.70.
Tweenvest scores Pharma-Bio Serv, Inc. across four factors: quality 60/100, value 67/100, growth 0/100, dividend 100/100. Its strongest factor is dividend.
PBSV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.99M
- Revenue (TTM)
- $9.48M
- P/E
- 43.73
- EPS
- 0.01
- Dividend yield
- 15.63%
- Beta (5Y)
- 0.73
- 52-week high
- $0.70
- 52-week low
- $0.32
- Avg volume (3M)
- —
- Shares outstanding
- 22.90M
- Employees
- 55
- Next earnings
- —
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.
- ISIN
- US71711N1000
- Founded
- 1993
- Listed since
- May 7, 2007
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Proteomics International Laboratories LtdASX: PIQ | $14.43M | AU$0.13 | +4.17% |
| Genetic Signatures LimitedASX: GSS | $13.31M | AU$0.08 | +6.33% |
| Malaysian Genomics Resource Centre BerhadKLSE: MGRC | $12.93M | RM0.35 | -2.78% |
| Welgene Biotech Co.,Ltd.TPEX: 6661 | $12.58M | NT$17.20 | +6.17% |
| Memphasys LimitedASX: MEM | $10.77M | AU$0.01 | -16.67% |
| China Health Group Inc.SEHK: 8225 | $10.02M | HK$0.08 | +12.86% |
| RBC Bioscience CorporationTPEX: 6848 | $9.55M | NT$21.40 | -0.23% |
| IDL Diagnostics AB (publ)OM: IDLDX | $8.89M | Skr0.39 | +4.32% |
Figures last refreshed Oct 11, 2026.